These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20103748)

  • 21. Direct-to-consumer prescription drug advertising: history, regulation, and issues.
    Huh J; DeLorme DE; Reid LN; An S
    Minn Med; 2010 Mar; 93(3):50-2. PubMed ID: 20429178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New DTCA Guidance--Enough to Empower Consumers?
    Robertson CT
    N Engl J Med; 2015 Sep; 373(12):1085-7. PubMed ID: 26287748
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug risks and free speech--can Congress ban consumer drug ads?
    Shuchman M
    N Engl J Med; 2007 May; 356(22):2236-9. PubMed ID: 17476002
    [No Abstract]   [Full Text] [Related]  

  • 24. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1995 Oct; 274(14):1109. PubMed ID: 7563473
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug and device litigation in the 21st century.
    Svitak LS; Goss PJ
    Spec Law Dig Health Care Law; 2001 Nov; (271):9-36. PubMed ID: 11802352
    [No Abstract]   [Full Text] [Related]  

  • 26. Direct-to-consumer advertising of drugs.
    Weinmeyer R
    Virtual Mentor; 2013 Nov; 15(11):954-8. PubMed ID: 24257087
    [No Abstract]   [Full Text] [Related]  

  • 27. Turning point or tipping point: new FDA draft guidances and the future of DTC advertising.
    Pitts PJ
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-259-61. PubMed ID: 15452001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manufacturers' promotion of off-label drug use: implications for drug safety.
    Zieve A; Carome MA
    Expert Opin Drug Saf; 2016 Sep; 15(9):1149-51. PubMed ID: 27145440
    [No Abstract]   [Full Text] [Related]  

  • 29. Hidden truth: The perils and protection of off-label drug and medical device promotion.
    Conko G
    Health Matrix Clevel; 2011; 21(1):149-87. PubMed ID: 21847900
    [No Abstract]   [Full Text] [Related]  

  • 30. Direct-to-consumer prescription drug advertising.
    Terzian TV
    Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573
    [No Abstract]   [Full Text] [Related]  

  • 31. FDA tightens rules on advertising.
    Josefson D
    BMJ; 1997 Aug; 315(7106):447. PubMed ID: 9284658
    [No Abstract]   [Full Text] [Related]  

  • 32. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages.
    Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586
    [No Abstract]   [Full Text] [Related]  

  • 33. Is the information "fair and balanced" in direct-to-consumer prescription drug websites?
    Huh J; Cude BJ
    J Health Commun; 2004; 9(6):529-40. PubMed ID: 15764451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The federal regulation of prescription drug advertising and promotion.
    Kessler DA; Pines WL
    JAMA; 1990 Nov; 264(18):2409-15. PubMed ID: 2231998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct-to-consumer advertising.
    Haddy FJ
    Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(3):38-9. PubMed ID: 20690556
    [No Abstract]   [Full Text] [Related]  

  • 37. Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Mackey TK
    Int J Health Policy Manag; 2016 Feb; 5(4):271-4. PubMed ID: 27239871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transparent reaction. Suppliers oppose FDA move to disclose more data.
    Rhea S
    Mod Healthc; 2010 Jul; 40(30):16. PubMed ID: 20695055
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA regulation of Internet pharmaceutical communications: strategies for improvement.
    Loza EL
    Food Drug Law J; 2000; 55(2):269-92. PubMed ID: 12269369
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?
    Khanfar N; Loudon D; Sircar-Ramsewak F
    Health Mark Q; 2007; 24(1-2):77-91. PubMed ID: 19042521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.